Mickle Travis C
- SEC CIK
- 0001638365
No open-market purchases or sales filed in the past year.
Current role at each company
- ZVRA Zevra Therapeutics, Inc.President & CEOas of May 25, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Mickle Travis C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 25, 2022 (view filing) | May 25 | Same day | Mickle Travis CPresident & CEO | PPurchase | +3.00K | $4.37 | +$13.1K | +8.2%39.5K after | 2 lots |
| May 25, 2022 (view filing) | May 25 | Same day | Mickle Travis CPresident & CEO | PPurchase | +10.0K | $4.39 | +$43.9K | +967.1%11.0K after | |
| Nov 23, 2021 (view filing) | Nov 18 | 5 daysLate | Mickle Travis CPresident & CEO | PPurchase | +2.25K | $8.23 | +$18.5K | +6.6%36.5K after | |
| Aug 30, 2021 (view filing) | Aug 30 | Same day | Mickle Travis CPresident & CEO | PPurchase | +5.00K | $8.92 | +$44.6K | +17.1%34.3K after |